5月份近七成股基上涨 鹏华医药科技股票涨12.4%

Group 1 - In May, 696 out of 1025 comparable ordinary equity funds achieved positive performance, representing 68% of the total [1] - The pharmaceutical-themed funds led the performance, with 15 funds showing monthly gains exceeding 10%, including Anxin Pharmaceutical Health Stock A and C, and Hongtu Innovation Medical Care Stock [1] - Anxin Pharmaceutical Health Stock A and C had gains of 15.35% and 15.31% respectively, while Hongtu Innovation Medical Care Stock gained 15.01% [1] Group 2 - Penghua Pharmaceutical Technology Stock A and C increased by 12.44% and 12.40% respectively, managed by veteran fund manager Jin Xiaofei [2] - Other notable pharmaceutical-themed funds with significant gains include Jianxin Medical Health Industry Stock and Invesco Great Wall Medical Industry Stock [2] - Funds heavily invested in technology stocks, such as Huian Trend Power Stock A and C, underperformed with declines of 9.74% and 9.69% respectively [2] Group 3 - Funds focused on advanced manufacturing and semiconductor industries, such as GF Advanced Manufacturing Stock and Chuangjin Hexin Chip Industry Stock, experienced declines ranging from 8.56% to 7.09% [3] - The top holdings of GF Advanced Manufacturing Stock include leading companies in manufacturing and technology sectors [3] - Financial performance of the funds in the semiconductor sector showed significant changes, with some funds experiencing a net value drop of 13.98% in the first quarter [3] Group 4 - The performance rankings of ordinary equity funds in May highlighted the top gainers and losers, with Anxin Pharmaceutical Health Stock A leading the gains [4] - The data indicates a clear trend where pharmaceutical funds outperformed technology-focused funds during this period [4] - The overall market sentiment reflected a preference for healthcare-related investments amid broader market fluctuations [4]